SAA1 Antikörper
Kurzübersicht für SAA1 Antikörper (ABIN7179313)
Target
Alle SAA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Protein G purified
-
Immunogen
- Recombinant Serum amyloid A-1 Protein
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 15mmol/L Sodium azide
Constituents: 0.1Mol/L Nacl -
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SAA1 (Serum Amyloid A1 (SAA1))
-
Andere Bezeichnung
- SAA1
-
Hintergrund
-
Background: Serum amyloid A protein, also named SAA, Amyloid protein A, Amyloid fibril protein AA, SAA1, SAA2 and PIG4, is an acute phase apolipoprotein reactant which is produced mostly by hepatocytes and under regulation of inflammatory cytokines. SAA1 is produced mainly in the liver and circulates in low levels in the blood. SAA1 may play a role in the immune system and facilitate the repair of injured tissues, it also acts as an antibacterial agent, and signals the migration of germ-fighting cells to sites of infection. SAA1 also functions as an apolipoprotein of the HDL complex. The SAA1 cleavage product a designated amyloid protein A is deposited systemically as amyloid in vital organs such as the liver, spleen, and kidneys in chronic inflammatory diseases patients. These deposits are extremely insoluble and resistant to proteolysis, they disrupt tissue structure and compromise performance.
Aliases: SAA1, Serum amyloid A-1 protein, Amyloid fibril protein AA
-
UniProt
- P0DJI8
-
Pathways
- Toll-Like Receptors Cascades
Target
-